EUVIMEDEUVIMED entdecken
Open Access

CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation

Anees Ahmed, Ann M Joseph, Jordan Zhou iD, Veronika Horn iD, Jazib Uddin iD, Mengze Lyu iD, Jeremy Goc iD, JRI Live Cell Bank, Robbyn E Sockolow, James B Wing iD, Eric Vivier iD, Shimon Sakaguchi iD und 1 weitere

Nature · 27.06.2024 · 630 (8018) · 976-983

DOI: 10.1038/s41586-024-07537-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature, online erschienen am 12.06.2024. Verfasst von Anees Ahmed und 12 weiteren Autor:innen. Beteiligte Einrichtung: Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology & Hepatology, Weill Cornell Medicine, Cornell University, New York, NY…. Hauptthemen laut MEDLINE: Immunity, Innate, Inflammation, Interleukin-23, Lymphocytes. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL-)23 is a major mediator and therapeutic target in chronic inflammatory diseases that also elicits tissue protection in the intestine at homeostasis or following acute infection1-4. However, the mechanisms that shape these beneficial versus pathological outcomes remain poorly understood. To address this gap in knowledge, we performed single-cell RNA sequencing on all IL-23 receptor-expressing cells in the intestine and their acute response to IL-23, revealing a dominance of T cells and group 3 innate lymphoid cells (ILC3s). Unexpectedly, we identified potent upregulation of the immunoregulatory checkpoint molecule cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) on ILC3s. This pathway was activated by gut microbes and IL-23 in a FOXO1- and STAT3-dependent manner. Mice lacking CTLA-4 on ILC3s exhibited reduced regulatory T cells, elevated inflammatory T cells and more-severe intestinal inflammation. IL-23 induction of CTLA-4+ ILC3s was necessary and sufficient to reduce co-stimulatory molecules and increase PD-L1 bioavailability on intestinal myeloid cells. Finally, human ILC3s upregulated CTLA-4 in response to IL-23 or gut inflammation and correlated with immunoregulation in inflammatory bowel disease. These results reveal ILC3-intrinsic CTLA-4 as an essential checkpoint that restrains the pathological outcomes of IL-23, suggesting that disruption of these lymphocytes, which occurs in inflammatory bowel disease5-7, contributes to chronic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateInflammationInterleukin-23LymphocytesAnimalsFemaleHumansMaleMiceCTLA-4 AntigenForkhead Box Protein O1Gastrointestinal MicrobiomeIntestinesMice, Inbred C57BLMyeloid CellsSingle-Cell Gene Expression AnalysisSTAT3 Transcription FactorT-Lymphocytes, RegulatoryB7-H1 AntigenInterleukin-23 Subunit p19

Substanzen

CTLA-4 AntigenForkhead Box Protein O1Interleukin-23STAT3 Transcription FactorCd274 protein, mouseB7-H1 AntigenCtla4 protein, mouseFoxo1 protein, mouseIl23a protein, mouseInterleukin-23 Subunit p19

Autor:innen und Institutionen

  • Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology & Hepatology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Department of Microbiology & Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Department of Pediatrics, Division of Gastroenterology, Hepatology, & Nutrition, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Laboratory of Experimental Immunology, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Laboratory of Human Single Cell Immunology, WPI IFReC, Osaka University, Suita, Japan.

ORCID-Profile: Jordan Zhou, Veronika Horn, Jazib Uddin, Mengze Lyu, Jeremy Goc, James B Wing, Eric Vivier, Shimon Sakaguchi, Gregory F Sonnenberg

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Ahmed, A., Joseph, A. M., Zhou, J., Horn, V., Uddin, J., Lyu, M., Goc, J., JRI Live Cell Bank, Sockolow, R. E., Wing, J. B., Vivier, E., Sakaguchi, S., & Sonnenberg, G. F. (2024). CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation. Nature, 630(8018), 976-983. https://doi.org/10.1038/s41586-024-07537-3

Vancouver

Ahmed A, Joseph AM, Zhou J, Horn V, Uddin J, Lyu M, et al. CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation. Nature. 2024;630(8018):976-983. doi:10.1038/s41586-024-07537-3

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Anees and Joseph, Ann M and Zhou, Jordan and Horn, Veronika and Uddin, Jazib and Lyu, Mengze and Goc, Jeremy and JRI Live Cell Bank, JRI Live Cell Bank and Sockolow, Robbyn E and Wing, James B and Vivier, Eric and Sakaguchi, Shimon and Sonnenberg, Gregory F},
  title = {CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation},
  journal = {Nature},
  year = {2024},
  volume = {630},
  number = {8018},
  pages = {976--983},
  doi = {10.1038/s41586-024-07537-3}
}
Kostenlos starten →